Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 474 (ZNF474) is a member of the C2H2-type zinc finger protein family, characterized by its predicted zinc ion binding activity and structural features that suggest a role as a transcription factor[1][3][8]. ZNF474 contains a SCAN domain, a conserved protein-protein interaction motif implicated in the selective oligomerization of zinc finger proteins, and is predominantly found in the testis, suggesting possible functions in spermatogenesis or tissue-specific gene regulation[1][2][6]. ZNF474 shares structural motifs with other transcription factors but lacks direct evidence as a therapeutic target, and there are currently no drugs or validated biomarkers specifically associated with this protein. While zinc finger proteins as a family can be dysregulated in cancer, no specific disease link or safety concerns have been described for ZNF474 to date[4][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 474 (ZNF474).